Efficacy and safety of cefixim and ciprofloxacin in acute cystitis (a multicenter randomized trial)
- Authors: Galkin VV1, Malev IV1, Dovgan' EV1, Kozlov SN1, Rafal'skiy VV1, Galkin VV1, Malev IV1, Dovgan EV1, Kozlov SN1, Rafalsky VV1
-
Affiliations:
- Issue: No 1 (2011)
- Pages: 13-16
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/278997
- ID: 278997
Cite item
Full Text
Abstract
About the authors
V V Galkin
I V Malev
E V Dovgan'
S N Kozlov
V V Rafal'skiy
Email: v.rafalskiy@mail.ru
V V Galkin
I V Malev
E V Dovgan
S N Kozlov
V V Rafalsky
References
- Рафальский В. В., Малев И. В., Деревицкий А. В. и др. Эффективность норфлоксацина при остром цистите в регионе с 10% уровнем резистентности E. coli к фторхинолонам: сравнительное рандомизированное исследование. Урология 2009; 3: 18-21.
- Faulkner R. D., Bohaychuk W., Desjardings R. E. et al. Pharmacokinetics of cefixime after once-a-day and twice-a-day dosing to steady state. J. Clin. Pharmacol. 1987; 27: 807-812.
- Рафальский В. В., Белокрысенко С. С., Малев И. В. и др. Чувствительность возбудителей инфекций мочевыводящих путей, выделенных в Российской Федерации, к пероральному цефлоспорину III поколения цефиксиму. Лечащий врач 2008; 8: 27-29.
- Iravani A., Richard G., Johnson D., Bryant A. A double-blinding, multicenter comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patient. Am. J. Med. 1988; 85: 17-25.
- Levenstein J., Summerfield P. J., Fourie S. et al. Comparison of cefixime and co-trimoxazole in acute uncomplicated urinary tract infection. A double-blind general practice study. South. Afr. Med. J. 1986; 70: 455-460.
- Naber K., Bjerklund-Johansen T., Bishop M. EAU guidelines for the management of urinary and male genital tract infections. European Association of Urology; 2006.
- Gonzalez M. A., Uribe F., Moisen S. D. et al. Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers. Antimicrob. Agents Chemother. 1984; 26: 741-744.
- Hooton T. M., Scholes D., Gupta K. et al. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. J. A. M. A. 2005; 293: 949- 955.
- Arredondo-Garcia J. L., Figueroa-Damian R., Rosas A. et al. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study. J. Antimicrob. Chemother. 2004; 54: 840-843.
- Vogel T., Verreault R., Gourdeau M. et al. Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial. Can. Med. Assoc. J. 2004; 170: 469-473.
- Iravani A., Tice A. D., McCarty J. et al. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected]. Arch. Intern. Med. 1995; 155: 485-494.
- Ceran N., Mert D., Kocdogan F. Y. et al. A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections. J. Infect. Chemother.
- Naber K. G., Schito G., Botto H. et al. Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for empiric therapy. Eur. Urol. 2008; 54: 1164-1178.
- Рафальский В. В., Страчунский Л. С., Бабкин П. А. и др. Резистентность возбудителей неосложненных инфекций мочевых путей в России. Урология 2006; 5: 34-37.
- Gillenwater J. Y., Howards S. S., Grayhack J. T. et al. Imflammatory diseases of the bladder. In: Sant G. R., ed. Adult and pediatric urology. Philadelphia: Lippincott Williams&Wilkins; 2002; 2: 2828-2839.